Eric J. Whitman

727 total citations
8 papers, 365 citations indexed

About

Eric J. Whitman is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Eric J. Whitman has authored 8 papers receiving a total of 365 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Pulmonary and Respiratory Medicine and 2 papers in Oncology. Recurrent topics in Eric J. Whitman's work include Prostate Cancer Diagnosis and Treatment (3 papers), Prostate Cancer Treatment and Research (3 papers) and Melanoma and MAPK Pathways (3 papers). Eric J. Whitman is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (3 papers), Prostate Cancer Treatment and Research (3 papers) and Melanoma and MAPK Pathways (3 papers). Eric J. Whitman collaborates with scholars based in United States. Eric J. Whitman's co-authors include Lee D. Cranmer, John F. Ward, René González, Karl D. Lewis, David H. Lawson, Amina Ali, Joseph Catlett, Bungo Furusato, Yongmei Chen and Wolfram E. Samlowski and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and The Journal of Urology.

In The Last Decade

Eric J. Whitman

8 papers receiving 359 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eric J. Whitman United States	7	190	183	98	97	27	8	365
Yuichi Ishikawa Japan	5	86 0.5×	208 1.1×	133 1.4×	102 1.1×	26 1.0×	8	329
Yunyi Kong China	9	207 1.1×	111 0.6×	86 0.9×	99 1.0×	26 1.0×	14	330
Mohamed Kabbout United States	9	128 0.7×	242 1.3×	126 1.3×	82 0.8×	19 0.7×	11	353
Cristina Quero Spain	10	73 0.4×	175 1.0×	86 0.9×	133 1.4×	31 1.1×	19	367
Karoliina Stefanius United States	8	126 0.7×	279 1.5×	181 1.8×	104 1.1×	31 1.1×	9	402
Jerome P. Richie United States	7	156 0.8×	94 0.5×	52 0.5×	96 1.0×	40 1.5×	10	277
Elaine Wiegert United States	7	131 0.7×	64 0.3×	59 0.6×	76 0.8×	11 0.4×	9	313
Divya Bhagirath United States	9	160 0.8×	385 2.1×	310 3.2×	69 0.7×	17 0.6×	15	500
Santiago Ponce-Aix Spain	11	233 1.2×	159 0.9×	59 0.6×	199 2.1×	23 0.9×	17	425
Weifei Fan China	14	77 0.4×	279 1.5×	174 1.8×	135 1.4×	15 0.6×	25	434

Countries citing papers authored by Eric J. Whitman

Since Specialization

Citations

This map shows the geographic impact of Eric J. Whitman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric J. Whitman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric J. Whitman more than expected).

Fields of papers citing papers by Eric J. Whitman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric J. Whitman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric J. Whitman. The network helps show where Eric J. Whitman may publish in the future.

Co-authorship network of co-authors of Eric J. Whitman

This figure shows the co-authorship network connecting the top 25 collaborators of Eric J. Whitman. A scholar is included among the top collaborators of Eric J. Whitman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric J. Whitman. Eric J. Whitman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Whitman, Eric J., Mark M. Pomerantz, Yongmei Chen, et al.. (2010). Prostate Cancer Risk Allele Specific for African Descent Associates with Pathologic Stage at Prostatectomy. Cancer Epidemiology Biomarkers & Prevention. 19(1). 1–8. 29 indexed citations

Rice, Kevin R., Yongmei Chen, Amina Ali, et al.. (2010). Evaluation of the ETS-Related Gene mRNA in Urine for the Detection of Prostate Cancer. Clinical Cancer Research. 16(5). 1572–1576. 43 indexed citations

Koh, Stephen S., Michael L. Opel, M. Gorre, et al.. (2009). Molecular classification of melanomas and nevi using gene expression microarray signatures and formalin-fixed and paraffin-embedded tissue. Modern Pathology. 22(4). 538–546. 35 indexed citations

Lewis, Karl D., Wolfram E. Samlowski, John F. Ward, et al.. (2009). A multi-center phase II evaluation of the small molecule survivin suppressor YM155 in patients with unresectable stage III or IV melanoma. Investigational New Drugs. 29(1). 161–166. 113 indexed citations

Whitman, Eric J., Jack Groskopf, Amina Ali, et al.. (2008). PCA3 Score Before Radical Prostatectomy Predicts Extracapsular Extension and Tumor Volume. The Journal of Urology. 180(5). 1975–1979. 129 indexed citations

Alexandrescu, Doru T, Karl D. Lewis, Wolfram E. Samlowski, et al.. (2007). A phase II study of YM155 administered as 168 hour continuous infusion in stage IV and unresectable stage III melanoma.. Molecular Cancer Therapeutics. 6. 4 indexed citations

Gonzalez, R., Karl D. Lewis, Wolfram E. Samlowski, et al.. (2007). A phase II study of YM155, a novel survivin suppressant, administered by 168 hour continuous infusion in patients with unresectable stage III or stage IV melanoma. Journal of Clinical Oncology. 25(18_suppl). 8538–8538. 6 indexed citations

Whitman, Eric J., Stephen A. Brassell, Inger L. Rosner, & Joel T. Moncur. (2007). Merkel Cell Carcinoma As a Solitary Metastasis to the Testis. Journal of Clinical Oncology. 25(24). 3785–3786. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact